Clinical trial design in the era of precision oncology: a rapidly evolving landscape

by VHIO

In our collective efforts to solve cancer sooner, tumor diversity represents one of the major challenges in more effectively targeting the specificities of individual cancers. Much progress has howe...

Read more

Mind the Byte and Prosilico sign a strategic partnership agreement

by Mind the Byte

Mind the Byte, a bioinformatics company located at the Barcelona Science Park (PCB) and at Copenhagen BioScience Park (COBIS), announces that it has just signed an agreement to share technology with t...

Read more

La mejora en el diagnóstico del Alzheimer permite realizar investigación en fases más precoces de la enfermedad

by Hospital Universitari de Bellvitge

El Dr. Ramon Reñé, responsable de la Unidad Funcional de Demencias del Hospital Universitario de Bellvitge (UFD-HUB), destaca que “la espectacular mejora en el diagnóstico precoz a la que hemos a...

Read more

A ‘Big Data’ approach to developing cancer drugs

by IBEC - Institut de Bioenginyeria de Catalunya

The researchers started from 1,000 cancer cell lines derived from 29 different cell types and different organs to simultaneously obtain their genetic alterations (mutations and copy number of genes), ...

Read more

Mind the Byte launches six new software to accelerate drug discovery

by Mind the Byte

The new products were officially presented at the BIO-Europe Spring congress in Stockholm this past April and now the aim is to continue promoting the SaaS in mature pharmaceutical and biotechnology m...

Read more

Reevalúan la utilidad de la quimioterapia clásica en cáncer de tiroides como alternativa o complemento a los nuevos fármacos

by Hospital Universitario Virgen de la Macarena

El trabajo realizado por los especialistas del Hospital Virgen Macarena analizan los resultados de los nuevos esquemas de tratamiento con quimioterapia clásica en este tipo de cánceres, y deja abier...

Read more

Iproteos continues to develop new drugs for diseases of the nervous system

by Fundació Bosch i Gimpera

The loan of the IFEM will enhance the advancement of the development of this drug to market as soon as possible. Iproteos applied successfully IPROTech their internal projects dedicated to schizophren...

Read more

Histocell and Ferrer announce that the preclinical studies of their traumatic spinal cord injury drug support its therapeutic potential

by Histocell

The preclinical research was presented by Dr. Francisco Javier Rodriguez, a specialist at the Toledo Hospital for Paraplegics. Clinical trials in patients in the acute stage will start in the first qu...

Read more

New anti-carcinogenic compounds with low toxicity that may decrease the side effects of chemotherapy

by Universitat Jaume I

The designed compounds have particularly high therapeutic effects on tumour cells of breast and colon and can be the basis for the development of oncological drugs of low toxicity and high selectivity...

Read more

Palobiofarma signs licensing agreement to develop novel adenosine-based immuno-oncology treatments

by Palobiofarma

Under the terms of the agreement Novartis will acquire exclusive global rights to develop, manufacture and commercialize Palobiofarma´s adenosine A2Areceptor antagonist PBF-509, currently entering Ph...

Read more

Ability Pharmaceuticals announces positive Phase 1/1b study results of ABTL0812 in cancer patients with advanced solid tumors

by Ability Pharma

Study confirms that ABTL0812 is extremely well tolerated and shows promising signs of clinical antitumor activity. The results will be presented at AACR-NCI-EORTC International Conference on Molecular...

Read more

IDIFARMA Extends Its GMP Clinical Manufacturing Services To New Dosage Forms

by Idifarma

IDIFARMA, a leading Spanish Contract Development and Manufacturing Organization, has recently obtained an extension of its authorization as GMP clinical manufacturer by the Spanish Medicines Agency...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Webinar: The importance of the disposabl...

by MICROPTIC S.L.

Microptic organizes a new free webinar on July 23rd: The importance of...

Photos Stream